A novel targeted delivery system for cancer treatment and diagnosis
Ended Cooperative Agreement Awarded Last action
- Award ID
- R44CA183287
- Recipient
-
Endurx Pharmaceuticals Inc. UEI KWKNEAQPAK43
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $1,709,711
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- Tucson, AZ 85741, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $435,490 | |
| Amendment | $1,051,862 | |
| Original award | $222,359 |
Quick answers
Who received award R44CA183287?
R44CA183287 was awarded to Endurx Pharmaceuticals Inc. by National Institutes of Health (Department of Health and Human Services) on September 1, 2014.
How much is award R44CA183287 worth?
$1,709,711 has been obligated on R44CA183287.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award